PMID: 42296968

Tirzepatide monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO).

Yin Yaqi, Ma Jianhua, Liu Dexue, Duan Wei, Cheng Zhifeng, Jiang Hongwei, Zhang Yawei, Wu Guangyu, Zhuang Haoxin, Gu Weijun

Med (New York, N.Y.) · 2026

pp. 101183

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.